The global market for Preventive Treatment of Migraines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Preventive treatment aims to reduce the frequency, duration and severity of migraine attacks, improve migraine-related disability, improve quality of life, reduce related psychological disorders caused by frequent or chronic headaches, and improve the response rate to acute treatment. And reduce dependence on acute treatment and avoid the occurrence of drug overuse headache.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Preventive Treatment of Migraines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Treatment of Migraines.

The Preventive Treatment of Migraines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preventive Treatment of Migraines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Preventive Treatment of Migraines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Preventive Treatment of Migraines Market Report

Report Metric	Details
Report Name	Preventive Treatment of Migraines Market
CAGR	5%
Segment by Type	Calcium Channel Blockers Anti-epileptic Drugs β-blockers Calcium Channel Modulators Antidepressants Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Biohaven, ELI LILLY AND CO, ABBVIE INC, Johnson and Johnson, Cipla Limited, Torrent Pharmaceuticals, Aa Pharma, Karnataka Antibiotics and Pharmaceuticals, Cadila Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Fdc, Alkem Laboratories, Intas Pharmaceuticals, PFIZER INC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventive Treatment of Migraines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventive Treatment of Migraines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Preventive Treatment of Migraines Market report?

Ans: The main players in the Preventive Treatment of Migraines Market are Biohaven, ELI LILLY AND CO, ABBVIE INC, Johnson and Johnson, Cipla Limited, Torrent Pharmaceuticals, Aa Pharma, Karnataka Antibiotics and Pharmaceuticals, Cadila Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Fdc, Alkem Laboratories, Intas Pharmaceuticals, PFIZER INC

What are the Application segmentation covered in the Preventive Treatment of Migraines Market report?

Ans: The Applications covered in the Preventive Treatment of Migraines Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Preventive Treatment of Migraines Market report?

Ans: The Types covered in the Preventive Treatment of Migraines Market report are Calcium Channel Blockers, Anti-epileptic Drugs, β-blockers, Calcium Channel Modulators, Antidepressants, Other

1 Preventive Treatment of Migraines Market Overview

1.1 Product Definition

1.2 Preventive Treatment of Migraines by Type

1.2.1 Global Preventive Treatment of Migraines Market Value Comparison by Type (2024 VS 2031)

1.2.2 Calcium Channel Blockers

1.2.3 Anti-epileptic Drugs

1.2.4 β-blockers

1.2.5 Calcium Channel Modulators

1.2.6 Antidepressants

1.2.7 Other

1.3 Preventive Treatment of Migraines by Application

1.3.1 Global Preventive Treatment of Migraines Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Preventive Treatment of Migraines Market Size Estimates and Forecasts

1.4.1 Global Preventive Treatment of Migraines Revenue 2020-2031

1.4.2 Global Preventive Treatment of Migraines Sales 2020-2031

1.4.3 Global Preventive Treatment of Migraines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Preventive Treatment of Migraines Market Competition by Manufacturers

2.1 Global Preventive Treatment of Migraines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Preventive Treatment of Migraines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Preventive Treatment of Migraines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Preventive Treatment of Migraines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Preventive Treatment of Migraines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Preventive Treatment of Migraines, Product Type & Application

2.7 Global Key Manufacturers of Preventive Treatment of Migraines, Date of Enter into This Industry

2.8 Global Preventive Treatment of Migraines Market Competitive Situation and Trends

2.8.1 Global Preventive Treatment of Migraines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Preventive Treatment of Migraines Players Market Share by Revenue

2.8.3 Global Preventive Treatment of Migraines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Preventive Treatment of Migraines Market Scenario by Region

3.1 Global Preventive Treatment of Migraines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Preventive Treatment of Migraines Sales by Region: 2020-2031

3.2.1 Global Preventive Treatment of Migraines Sales by Region: 2020-2025

3.2.2 Global Preventive Treatment of Migraines Sales by Region: 2026-2031

3.3 Global Preventive Treatment of Migraines Revenue by Region: 2020-2031

3.3.1 Global Preventive Treatment of Migraines Revenue by Region: 2020-2025

3.3.2 Global Preventive Treatment of Migraines Revenue by Region: 2026-2031

3.4 North America Preventive Treatment of Migraines Market Facts & Figures by Country

3.4.1 North America Preventive Treatment of Migraines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Preventive Treatment of Migraines Sales by Country (2020-2031)

3.4.3 North America Preventive Treatment of Migraines Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Preventive Treatment of Migraines Market Facts & Figures by Country

3.5.1 Europe Preventive Treatment of Migraines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Preventive Treatment of Migraines Sales by Country (2020-2031)

3.5.3 Europe Preventive Treatment of Migraines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Preventive Treatment of Migraines Market Facts & Figures by Region

3.6.1 Asia Pacific Preventive Treatment of Migraines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Preventive Treatment of Migraines Sales by Region (2020-2031)

3.6.3 Asia Pacific Preventive Treatment of Migraines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Preventive Treatment of Migraines Market Facts & Figures by Country

3.7.1 Latin America Preventive Treatment of Migraines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Preventive Treatment of Migraines Sales by Country (2020-2031)

3.7.3 Latin America Preventive Treatment of Migraines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Preventive Treatment of Migraines Market Facts & Figures by Country

3.8.1 Middle East and Africa Preventive Treatment of Migraines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Preventive Treatment of Migraines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Preventive Treatment of Migraines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Preventive Treatment of Migraines Sales by Type (2020-2031)

4.1.1 Global Preventive Treatment of Migraines Sales by Type (2020-2025)

4.1.2 Global Preventive Treatment of Migraines Sales by Type (2026-2031)

4.1.3 Global Preventive Treatment of Migraines Sales Market Share by Type (2020-2031)

4.2 Global Preventive Treatment of Migraines Revenue by Type (2020-2031)

4.2.1 Global Preventive Treatment of Migraines Revenue by Type (2020-2025)

4.2.2 Global Preventive Treatment of Migraines Revenue by Type (2026-2031)

4.2.3 Global Preventive Treatment of Migraines Revenue Market Share by Type (2020-2031)

4.3 Global Preventive Treatment of Migraines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Preventive Treatment of Migraines Sales by Application (2020-2031)

5.1.1 Global Preventive Treatment of Migraines Sales by Application (2020-2025)

5.1.2 Global Preventive Treatment of Migraines Sales by Application (2026-2031)

5.1.3 Global Preventive Treatment of Migraines Sales Market Share by Application (2020-2031)

5.2 Global Preventive Treatment of Migraines Revenue by Application (2020-2031)

5.2.1 Global Preventive Treatment of Migraines Revenue by Application (2020-2025)

5.2.2 Global Preventive Treatment of Migraines Revenue by Application (2026-2031)

5.2.3 Global Preventive Treatment of Migraines Revenue Market Share by Application (2020-2031)

5.3 Global Preventive Treatment of Migraines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Biohaven

6.1.1 Biohaven Company Information

6.1.2 Biohaven Description and Business Overview

6.1.3 Biohaven Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Biohaven Preventive Treatment of Migraines Product Portfolio

6.1.5 Biohaven Recent Developments/Updates

6.2 ELI LILLY AND CO

6.2.1 ELI LILLY AND CO Company Information

6.2.2 ELI LILLY AND CO Description and Business Overview

6.2.3 ELI LILLY AND CO Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 ELI LILLY AND CO Preventive Treatment of Migraines Product Portfolio

6.2.5 ELI LILLY AND CO Recent Developments/Updates

6.3 ABBVIE INC

6.3.1 ABBVIE INC Company Information

6.3.2 ABBVIE INC Description and Business Overview

6.3.3 ABBVIE INC Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 ABBVIE INC Preventive Treatment of Migraines Product Portfolio

6.3.5 ABBVIE INC Recent Developments/Updates

6.4 Johnson and Johnson

6.4.1 Johnson and Johnson Company Information

6.4.2 Johnson and Johnson Description and Business Overview

6.4.3 Johnson and Johnson Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Johnson and Johnson Preventive Treatment of Migraines Product Portfolio

6.4.5 Johnson and Johnson Recent Developments/Updates

6.5 Cipla Limited

6.5.1 Cipla Limited Company Information

6.5.2 Cipla Limited Description and Business Overview

6.5.3 Cipla Limited Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Cipla Limited Preventive Treatment of Migraines Product Portfolio

6.5.5 Cipla Limited Recent Developments/Updates

6.6 Torrent Pharmaceuticals

6.6.1 Torrent Pharmaceuticals Company Information

6.6.2 Torrent Pharmaceuticals Description and Business Overview

6.6.3 Torrent Pharmaceuticals Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Torrent Pharmaceuticals Preventive Treatment of Migraines Product Portfolio

6.6.5 Torrent Pharmaceuticals Recent Developments/Updates

6.7 Aa Pharma

6.7.1 Aa Pharma Company Information

6.7.2 Aa Pharma Description and Business Overview

6.7.3 Aa Pharma Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Aa Pharma Preventive Treatment of Migraines Product Portfolio

6.7.5 Aa Pharma Recent Developments/Updates

6.8 Karnataka Antibiotics and Pharmaceuticals

6.8.1 Karnataka Antibiotics and Pharmaceuticals Company Information

6.8.2 Karnataka Antibiotics and Pharmaceuticals Description and Business Overview

6.8.3 Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Product Portfolio

6.8.5 Karnataka Antibiotics and Pharmaceuticals Recent Developments/Updates

6.9 Cadila Pharmaceuticals

6.9.1 Cadila Pharmaceuticals Company Information

6.9.2 Cadila Pharmaceuticals Description and Business Overview

6.9.3 Cadila Pharmaceuticals Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cadila Pharmaceuticals Preventive Treatment of Migraines Product Portfolio

6.9.5 Cadila Pharmaceuticals Recent Developments/Updates

6.10 Orchid Chemicals and Pharmaceuticals

6.10.1 Orchid Chemicals and Pharmaceuticals Company Information

6.10.2 Orchid Chemicals and Pharmaceuticals Description and Business Overview

6.10.3 Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Product Portfolio

6.10.5 Orchid Chemicals and Pharmaceuticals Recent Developments/Updates

6.11 Fdc

6.11.1 Fdc Company Information

6.11.2 Fdc Description and Business Overview

6.11.3 Fdc Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Fdc Preventive Treatment of Migraines Product Portfolio

6.11.5 Fdc Recent Developments/Updates

6.12 Alkem Laboratories

6.12.1 Alkem Laboratories Company Information

6.12.2 Alkem Laboratories Description and Business Overview

6.12.3 Alkem Laboratories Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Alkem Laboratories Preventive Treatment of Migraines Product Portfolio

6.12.5 Alkem Laboratories Recent Developments/Updates

6.13 Intas Pharmaceuticals

6.13.1 Intas Pharmaceuticals Company Information

6.13.2 Intas Pharmaceuticals Description and Business Overview

6.13.3 Intas Pharmaceuticals Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Intas Pharmaceuticals Preventive Treatment of Migraines Product Portfolio

6.13.5 Intas Pharmaceuticals Recent Developments/Updates

6.14 PFIZER INC

6.14.1 PFIZER INC Company Information

6.14.2 PFIZER INC Description and Business Overview

6.14.3 PFIZER INC Preventive Treatment of Migraines Sales, Revenue and Gross Margin (2020-2025)

6.14.4 PFIZER INC Preventive Treatment of Migraines Product Portfolio

6.14.5 PFIZER INC Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Preventive Treatment of Migraines Industry Chain Analysis

7.2 Preventive Treatment of Migraines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Preventive Treatment of Migraines Production Mode & Process Analysis

7.4 Preventive Treatment of Migraines Sales and Marketing

7.4.1 Preventive Treatment of Migraines Sales Channels

7.4.2 Preventive Treatment of Migraines Distributors

7.5 Preventive Treatment of Migraines Customer Analysis

8 Preventive Treatment of Migraines Market Dynamics

8.1 Preventive Treatment of Migraines Industry Trends

8.2 Preventive Treatment of Migraines Market Drivers

8.3 Preventive Treatment of Migraines Market Challenges

8.4 Preventive Treatment of Migraines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Torrent Pharmaceuticals

Aa Pharma

Karnataka Antibiotics and Pharmaceuticals

Cadila Pharmaceuticals

Orchid Chemicals and Pharmaceuticals

FDC

Alkem Laboratories

Intas Pharmaceuticals

Pfizer Inc

Biohaven

List of Tables

Table 1. Global Preventive Treatment of Migraines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Preventive Treatment of Migraines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Preventive Treatment of Migraines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Preventive Treatment of Migraines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Preventive Treatment of Migraines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Preventive Treatment of Migraines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Preventive Treatment of Migraines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Preventive Treatment of Migraines Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Preventive Treatment of Migraines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Preventive Treatment of Migraines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Preventive Treatment of Migraines, Product Type & Application

Table 12. Global Key Manufacturers of Preventive Treatment of Migraines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Preventive Treatment of Migraines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Treatment of Migraines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Preventive Treatment of Migraines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Preventive Treatment of Migraines Sales by Region (2020-2025) & (K Units)

Table 18. Global Preventive Treatment of Migraines Sales Market Share by Region (2020-2025)

Table 19. Global Preventive Treatment of Migraines Sales by Region (2026-2031) & (K Units)

Table 20. Global Preventive Treatment of Migraines Sales Market Share by Region (2026-2031)

Table 21. Global Preventive Treatment of Migraines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Preventive Treatment of Migraines Revenue Market Share by Region (2020-2025)

Table 23. Global Preventive Treatment of Migraines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Preventive Treatment of Migraines Revenue Market Share by Region (2026-2031)

Table 25. North America Preventive Treatment of Migraines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Preventive Treatment of Migraines Sales by Country (2020-2025) & (K Units)

Table 27. North America Preventive Treatment of Migraines Sales by Country (2026-2031) & (K Units)

Table 28. North America Preventive Treatment of Migraines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Preventive Treatment of Migraines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Preventive Treatment of Migraines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Preventive Treatment of Migraines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Preventive Treatment of Migraines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Preventive Treatment of Migraines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Preventive Treatment of Migraines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Preventive Treatment of Migraines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Preventive Treatment of Migraines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Preventive Treatment of Migraines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Preventive Treatment of Migraines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Preventive Treatment of Migraines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Preventive Treatment of Migraines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Preventive Treatment of Migraines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Preventive Treatment of Migraines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Preventive Treatment of Migraines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Preventive Treatment of Migraines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Preventive Treatment of Migraines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Preventive Treatment of Migraines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Preventive Treatment of Migraines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Preventive Treatment of Migraines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Preventive Treatment of Migraines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Preventive Treatment of Migraines Sales (K Units) by Type (2020-2025)

Table 51. Global Preventive Treatment of Migraines Sales (K Units) by Type (2026-2031)

Table 52. Global Preventive Treatment of Migraines Sales Market Share by Type (2020-2025)

Table 53. Global Preventive Treatment of Migraines Sales Market Share by Type (2026-2031)

Table 54. Global Preventive Treatment of Migraines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Preventive Treatment of Migraines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Preventive Treatment of Migraines Revenue Market Share by Type (2020-2025)

Table 57. Global Preventive Treatment of Migraines Revenue Market Share by Type (2026-2031)

Table 58. Global Preventive Treatment of Migraines Price (US$/Unit) by Type (2020-2025)

Table 59. Global Preventive Treatment of Migraines Price (US$/Unit) by Type (2026-2031)

Table 60. Global Preventive Treatment of Migraines Sales (K Units) by Application (2020-2025)

Table 61. Global Preventive Treatment of Migraines Sales (K Units) by Application (2026-2031)

Table 62. Global Preventive Treatment of Migraines Sales Market Share by Application (2020-2025)

Table 63. Global Preventive Treatment of Migraines Sales Market Share by Application (2026-2031)

Table 64. Global Preventive Treatment of Migraines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Preventive Treatment of Migraines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Preventive Treatment of Migraines Revenue Market Share by Application (2020-2025)

Table 67. Global Preventive Treatment of Migraines Revenue Market Share by Application (2026-2031)

Table 68. Global Preventive Treatment of Migraines Price (US$/Unit) by Application (2020-2025)

Table 69. Global Preventive Treatment of Migraines Price (US$/Unit) by Application (2026-2031)

Table 70. Biohaven Company Information

Table 71. Biohaven Description and Business Overview

Table 72. Biohaven Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Biohaven Preventive Treatment of Migraines Product

Table 74. Biohaven Recent Developments/Updates

Table 75. ELI LILLY AND CO Company Information

Table 76. ELI LILLY AND CO Description and Business Overview

Table 77. ELI LILLY AND CO Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. ELI LILLY AND CO Preventive Treatment of Migraines Product

Table 79. ELI LILLY AND CO Recent Developments/Updates

Table 80. ABBVIE INC Company Information

Table 81. ABBVIE INC Description and Business Overview

Table 82. ABBVIE INC Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. ABBVIE INC Preventive Treatment of Migraines Product

Table 84. ABBVIE INC Recent Developments/Updates

Table 85. Johnson and Johnson Company Information

Table 86. Johnson and Johnson Description and Business Overview

Table 87. Johnson and Johnson Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Johnson and Johnson Preventive Treatment of Migraines Product

Table 89. Johnson and Johnson Recent Developments/Updates

Table 90. Cipla Limited Company Information

Table 91. Cipla Limited Description and Business Overview

Table 92. Cipla Limited Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Cipla Limited Preventive Treatment of Migraines Product

Table 94. Cipla Limited Recent Developments/Updates

Table 95. Torrent Pharmaceuticals Company Information

Table 96. Torrent Pharmaceuticals Description and Business Overview

Table 97. Torrent Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Torrent Pharmaceuticals Preventive Treatment of Migraines Product

Table 99. Torrent Pharmaceuticals Recent Developments/Updates

Table 100. Aa Pharma Company Information

Table 101. Aa Pharma Description and Business Overview

Table 102. Aa Pharma Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Aa Pharma Preventive Treatment of Migraines Product

Table 104. Aa Pharma Recent Developments/Updates

Table 105. Karnataka Antibiotics and Pharmaceuticals Company Information

Table 106. Karnataka Antibiotics and Pharmaceuticals Description and Business Overview

Table 107. Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Karnataka Antibiotics and Pharmaceuticals Preventive Treatment of Migraines Product

Table 109. Karnataka Antibiotics and Pharmaceuticals Recent Developments/Updates

Table 110. Cadila Pharmaceuticals Company Information

Table 111. Cadila Pharmaceuticals Description and Business Overview

Table 112. Cadila Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Cadila Pharmaceuticals Preventive Treatment of Migraines Product

Table 114. Cadila Pharmaceuticals Recent Developments/Updates

Table 115. Orchid Chemicals and Pharmaceuticals Company Information

Table 116. Orchid Chemicals and Pharmaceuticals Description and Business Overview

Table 117. Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Orchid Chemicals and Pharmaceuticals Preventive Treatment of Migraines Product

Table 119. Orchid Chemicals and Pharmaceuticals Recent Developments/Updates

Table 120. Fdc Company Information

Table 121. Fdc Description and Business Overview

Table 122. Fdc Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Fdc Preventive Treatment of Migraines Product

Table 124. Fdc Recent Developments/Updates

Table 125. Alkem Laboratories Company Information

Table 126. Alkem Laboratories Description and Business Overview

Table 127. Alkem Laboratories Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Alkem Laboratories Preventive Treatment of Migraines Product

Table 129. Alkem Laboratories Recent Developments/Updates

Table 130. Intas Pharmaceuticals Company Information

Table 131. Intas Pharmaceuticals Description and Business Overview

Table 132. Intas Pharmaceuticals Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Intas Pharmaceuticals Preventive Treatment of Migraines Product

Table 134. Intas Pharmaceuticals Recent Developments/Updates

Table 135. PFIZER INC Company Information

Table 136. PFIZER INC Description and Business Overview

Table 137. PFIZER INC Preventive Treatment of Migraines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. PFIZER INC Preventive Treatment of Migraines Product

Table 139. PFIZER INC Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Preventive Treatment of Migraines Distributors List

Table 143. Preventive Treatment of Migraines Customers List

Table 144. Preventive Treatment of Migraines Market Trends

Table 145. Preventive Treatment of Migraines Market Drivers

Table 146. Preventive Treatment of Migraines Market Challenges

Table 147. Preventive Treatment of Migraines Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Preventive Treatment of Migraines

Figure 2. Global Preventive Treatment of Migraines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Preventive Treatment of Migraines Market Share by Type: 2024 & 2031

Figure 4. Calcium Channel Blockers Product Picture

Figure 5. Anti-epileptic Drugs Product Picture

Figure 6. β-blockers Product Picture

Figure 7. Calcium Channel Modulators Product Picture

Figure 8. Antidepressants Product Picture

Figure 9. Other Product Picture

Figure 10. Global Preventive Treatment of Migraines Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Preventive Treatment of Migraines Market Share by Application: 2024 & 2031

Figure 12. Hospital

Figure 13. Clinic

Figure 14. Other

Figure 15. Global Preventive Treatment of Migraines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Preventive Treatment of Migraines Market Size (2020-2031) & (US$ Million)

Figure 17. Global Preventive Treatment of Migraines Sales (2020-2031) & (K Units)

Figure 18. Global Preventive Treatment of Migraines Average Price (US$/Unit) & (2020-2031)

Figure 19. Preventive Treatment of Migraines Report Years Considered

Figure 20. Preventive Treatment of Migraines Sales Share by Manufacturers in 2024

Figure 21. Global Preventive Treatment of Migraines Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Preventive Treatment of Migraines Players: Market Share by Revenue in Preventive Treatment of Migraines in 2024

Figure 23. Preventive Treatment of Migraines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Preventive Treatment of Migraines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Preventive Treatment of Migraines Sales Market Share by Country (2020-2031)

Figure 26. North America Preventive Treatment of Migraines Revenue Market Share by Country (2020-2031)

Figure 27. United States Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Preventive Treatment of Migraines Sales Market Share by Country (2020-2031)

Figure 30. Europe Preventive Treatment of Migraines Revenue Market Share by Country (2020-2031)

Figure 31. Germany Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Preventive Treatment of Migraines Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Preventive Treatment of Migraines Revenue Market Share by Region (2020-2031)

Figure 38. China Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Preventive Treatment of Migraines Sales Market Share by Country (2020-2031)

Figure 46. Latin America Preventive Treatment of Migraines Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Preventive Treatment of Migraines Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Preventive Treatment of Migraines Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Preventive Treatment of Migraines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Preventive Treatment of Migraines by Type (2020-2031)

Figure 56. Global Revenue Market Share of Preventive Treatment of Migraines by Type (2020-2031)

Figure 57. Global Preventive Treatment of Migraines Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Preventive Treatment of Migraines by Application (2020-2031)

Figure 59. Global Revenue Market Share of Preventive Treatment of Migraines by Application (2020-2031)

Figure 60. Global Preventive Treatment of Migraines Price (US$/Unit) by Application (2020-2031)

Figure 61. Preventive Treatment of Migraines Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Migraine Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Migraine Drugs Market Research Report 2025

Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preventive Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Migraine Wearables Market Research Report 2024

Migraine Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Triptans for Migraine Headaches Market Research Report 2025

Global Oral Migraine Drugs Market Research Report 2025

Cluster Headache Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stroke Prevention in Atrial Fibrillation SPAF Treatment Market Research Report 2024

Global Anti snoring Treatment Market Insights Forecast to 2030

Global Triptan Market Insights Forecast to 2030

Global Melasma Treatments Market Research Report 2024

Global Acute Migraine Treatments Market Research Report 2024

Global Vertigo Treatments Market Research Report 2024

Global Central Nervous Treatment Program Market Research Report 2024

Mood Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Acromegaly Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions